Clark Michael, Kaufman Valerie, Fulks Michael, Dolan Vera F, Stout Robert L
J Insur Med. 2014;44(1):7-16.
Quantify the independent value of NT-proBNP in predicting all-cause mortality for individual life insurance applicants and establish risk-based reference ranges.
By use of the Social Security Death Master File and multivariate analysis, relative mortality was determined for 144,027 life insurance applicants tested (almost all routinely rather than for cause) for NT-proBNP along with other laboratory testing and measurement of BP and BMI.
Risk increased substantially for NT-proBNP values > 300 pg/mL in women and > 200 pg/mL in men after age, smoking status and other cardiovascular risk factors were accounted for. The relative risk reached > 10 fold at NT-proBNP levels > 1000 pg/mL. For those age 50 to 89 and denying a history of heart disease, this level occurred in only 0.5% of applicants but was present in 7% of all deaths.
NT-proBNP is a strong independent predictor of all-cause mortality but values associated with increased risk vary by sex.
量化N末端B型利钠肽原(NT-proBNP)在预测个人人寿保险申请人全因死亡率方面的独立价值,并建立基于风险的参考范围。
通过使用社会保障死亡主文件和多变量分析,确定了144,027名接受NT-proBNP检测(几乎所有检测都是常规检测而非针对特定病因)的人寿保险申请人的相对死亡率,同时还进行了其他实验室检测以及血压和体重指数的测量。
在考虑年龄、吸烟状况和其他心血管危险因素后,女性NT-proBNP值>300 pg/mL且男性>200 pg/mL时,风险大幅增加。NT-proBNP水平>1000 pg/mL时,相对风险达到>10倍。对于年龄在50至89岁且否认有心脏病史的人,该水平仅在0.5%的申请人中出现,但在所有死亡病例中占7%。
NT-proBNP是全因死亡率的强有力独立预测指标,但与风险增加相关的值因性别而异。